par Awada, Ahmad
;Gil, Thierry
;de Valeriola, Dominique
;Dubuisson, Michel
;Lalami, Yassine
;Moerman, C;Palmer, P;De Porre, Peter;Zhang, Steven;Piccart-Gebhart, Martine
; [et al.]
Référence Current medical research and opinion, 23, 5, page (991-1003)
Publication Publié, 2007-05






Référence Current medical research and opinion, 23, 5, page (991-1003)
Publication Publié, 2007-05
Article révisé par les pairs
Titre: |
|
Auteur: | Awada, Ahmad; Gil, Thierry; de Valeriola, Dominique; Dubuisson, Michel; Lalami, Yassine; Moerman, C; Palmer, P; De Porre, Peter; Zhang, Steven; Piccart-Gebhart, Martine; et al. |
Informations sur la publication: | Current medical research and opinion, 23, 5, page (991-1003) |
Statut de publication: | Publié, 2007-05 |
Sujet CREF: | Sciences bio-médicales et agricoles |
Mots-clés: | Docetaxel |
Farnesyltransferase inhibitor | |
Pharmacokinetics | |
Phase I | |
Solid cancer | |
Tipifarnib | |
MeSH keywords: | Adult |
Aged | |
Antineoplastic Combined Chemotherapy Protocols -- adverse effects | |
Antineoplastic Combined Chemotherapy Protocols -- pharmacokinetics | |
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use | |
Breast Neoplasms -- drug therapy | |
Breast Neoplasms -- pathology | |
Dose-Response Relationship, Drug | |
Drug Administration Routes | |
Drug Administration Schedule | |
Drug Interactions | |
Female | |
Humans | |
Immune System -- drug effects | |
Male | |
Maximum Tolerated Dose | |
Middle Aged | |
Neoplasms -- drug therapy | |
Neoplasms -- pathology | |
Quinolones -- administration & dosage | |
Quinolones -- adverse effects | |
Quinolones -- pharmacokinetics | |
Taxoids -- administration & dosage | |
Taxoids -- adverse effects | |
Taxoids -- pharmacokinetics | |
Treatment Outcome | |
Note générale: | Clinical Trial, Phase I |
Journal Article | |
Research Support, Non-U.S. Gov't | |
Langue: | Anglais |
Identificateurs: | urn:issn:0300-7995 |
info:doi/10.1185/030079907X178810 | |
info:scp/34249022680 | |
info:pmid/17519066 |